Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
22,709,672
-
Share change
-
+2,541,241
-
Total reported value
-
$381,075,755
-
Put/Call ratio
-
10%
-
Price per share
-
$16.78
-
Number of holders
-
78
-
Value change
-
-$69,885,312
-
Number of buys
-
46
-
Number of sells
-
52
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q2 2022
As of 30 Jun 2022,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,709,672 shares.
The largest 10 holders included
Deep Track Capital, LP, Logos Global Management LP, Point72 Asset Management, L.P., JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Paradigm Biocapital Advisors LP, SAMLYN CAPITAL, LLC, SV Health Investors, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.